FIG 1.

Kill curve activity of simulations for CFZ administered at 2 g every 8 h in the ex vivo SEV model in standard media and in NaHCO3-supplemented media against MRSA strains 11-11 (A), MW2 (B), COL (C), and BMC-1001 (D). The dashed line indicates untreated growth in CAMHB-Tris, and the solid lines indicate CFZ regimens. *, P < 0.05 versus CAMHB; **, P < 0.05 versus CAMHB plus 25 mM NaHCO3 media.